U.S. stocks traded mixed on cautiousness ahead of FOMC meeting and Fed Reserve''''s decision on interest rates. Blue-chip stocks declined while tech shares showed some strength with Palm and Apple rising 2%. The drug sector posted weakness with AstraZeneca and Bristol-Myers among the worst performers. Energy stocks were also sent lower by a decline in oil prices.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
More:
